Keyphrases
Testicular Cancer
81%
Germ Cell Tumor
78%
Bleomycin
45%
Cisplatin
38%
Etoposide
38%
Cancer Patients
30%
Testicular Cancer Survivors
23%
Population-based Study
22%
Luteinizing Hormone
21%
Prognostic Factors
20%
National Cohort Study
20%
Stage I Seminoma
20%
Orchiectomy
19%
Hazard Ratio
18%
Testicle
17%
Glomerular Filtration Rate
17%
Radiotherapy
16%
Total Testosterone
16%
Cancer Database
15%
Late Relapse
14%
Surveillance Program
14%
Relapse Risk
14%
Nonseminoma
14%
Late Toxicity
14%
Second Malignant Neoplasm
13%
Leydig Cell Dysfunction
13%
Treatment Results
13%
Chemotherapy
12%
Cause of Death
12%
Serum Levels
12%
High Risk
12%
Testicular Germ Cell Tumor
11%
Renal Impairment
11%
Population-based Cohort
11%
Carcinoma in Situ Testis
11%
Reproductive Hormones
11%
Testosterone Deficiency
11%
Treatment Options
11%
Disease-specific Survival
11%
Tumor Size
10%
Overall Survival
10%
Retrospective Research
10%
Multiple Relapses
10%
Cancer Relapse
10%
Longitudinal Change
10%
Testosterone Hormone
10%
Metabolic Syndrome
10%
Pulmonary Function
10%
Ecological Succession
10%
During Pregnancy
10%
Medicine and Dentistry
Testis Cancer
100%
Germ Cell Cancer
85%
Etoposide
43%
Bleomycin
43%
Cisplatin
43%
Seminoma
36%
Malignant Neoplasm
25%
Orchiectomy
24%
Luteinizing Hormone
21%
Prognostic Factor
20%
Testes
20%
Carcinoma in Situ
20%
Cohort Analysis
20%
Hazard Ratio
18%
Radiation Therapy
15%
Contralateral
15%
Interstitial Cell
14%
Clinical Stage
14%
Neoplasm
13%
Disease Specific Survival
12%
Proportional Hazards Model
11%
Overall Survival
11%
Androgen Deficiency
11%
Reproductive Hormone
11%
Lung Function
10%
Meta-Analysis
10%
Systematic Review
10%
Recurrent Disease
10%
Adjuvant Radiotherapy
10%
Glomerular Filtration Rate
10%
Metabolic Syndrome
10%
Recurrence Risk
9%
Adjuvant Therapy
8%
Lung Function Test
7%
Patient Characteristics
7%
Kidney Function
7%
Late Effect
7%
Outcome Assessment
7%
Cardiovascular Disease
7%
Chorionic Gonadotropin
6%
Cumulative Incidence
6%
Standardized Mortality Ratio
6%
Disease
5%
Tumor Marker
5%
Disseminated Disease
5%
